In both 2-D and 3-D cell culture models, expression of ERRF sensitizes intrinsically resistant ERBB2 positive breast cancer cells to lapatinib (Figure 2); and in vivo tumorigenesis assay confirmed the effect (Figure 4). This evidence concerns the gene SRARP and breast cancer.